SUPERNUS PHARMACEUTICALS, INC.
SUPN · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Khattar Jack A.: Form 4
Insider disclosure · Filed · Report period 12 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- SUPN · 868459108 - Common Stock, par value $0.001 per share
Company details and SEC sources
CIK 0001356576 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SUPN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 9715 Key West Avenue, Rockville, MD, 20850
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields